Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.315
+0.0051.61%
Volume:587.10K
Turnover:182.34K
Market Cap:189.12M
PE:-11.26
High:0.315
Open:0.305
Low:0.305
Close:0.310
52wk High:0.665
52wk Low:0.157
Shares:600.40M
Float Shares:467.70M
Volume Ratio:0.43
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.028
EPS(LYR):-0.024
ROE:-594.54%
ROA:-58.27%
PB:-112.50
PE(LYR):-13.32

Loading ...

Company Profile

Company Name:
DIMERIX LTD
Exchange:
ASX
Establishment Date:
- -
Employees:
15
Office Location:
425 Smith Street,Fitzroy,Victoria,Australia
Zip Code:
3065
Fax:
61 8 9388 8256
Introduction:
Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.